Better Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-31.57	-39.76	-40.34	-6.39	-5.8
Depreciation & Amortization	3.11	2.73	1.62	0.08	0.07
Share-Based Compensation	1.76	1.82	0.65	0.23	0.08
Other Operating Activities	0.61	6.28	7.25	0.31	-0.58
Operating Cash Flow	-26.08	-28.93	-30.82	-5.77	-6.22
Capital Expenditures	-1.39	-1.18	-1.07	-2.31	-2.74
Other Investing Activities	0.07	-	-	-	-
Investing Cash Flow	-1.32	-1.18	-1.07	-2.31	-2.74
Common Stock Issued	12.68	0.26	-14.87	0	0
Other Financing Activities	-0.98	5.03	14.94	7.45	8.7
Financing Cash Flow	11.69	5.28	0.07	7.45	8.7
Net Cash Flow	-15.71	-24.83	40.44	-0.63	-0.25
Free Cash Flow	-27.47	-30.11	-31.89	-8.08	-8.95
Free Cash Flow Margin	-	-	-	-100987.50%	-49738.89%
Free Cash Flow Per Share	-0.71	-1.28	-1.35	-1.07	-0.38

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.